OOIR: Observatory of International Research

Papers

(The median citation count of Diabetes & Vascular Disease Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature	59
Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors	38
Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice	26
Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats	21
Role of platelet-derived growth factor in type II diabetes mellitus and its complications	21
Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection	18
The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study	17
The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study	16
High myopia is protective against diabetic retinopathy via thinning retinal vein: A report from Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT)	14
EP4 signalling is essential for controlling islet inflammation by causing a shift in macrophage polarization in obesity/type 2 diabetes	12
Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study	11
High hemoglobin glycation index is associated with increased systemic arterial stiffness independent of hyperglycemia in real-world Japanese population: A cross	11
Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy	10
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry	9
Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques	9
Timed physical exercise does not influence circadian rhythms and glucose tolerance in rotating night shift workers: The EuRhythDia study	8
Evaluation of the relationship between cardiac autonomic function and glucose variability and HOMA-IR in prediabetes	8
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME^®	8
Comparative study of microvascular structural changes in the gestational diabetic placenta	8
Skin microvascular reactivity correlates to clinical microangiopathy in type 1 diabetes: A pilot study	7
Impaired subendocardial perfusion in patients with metabolic syndrome	7
Accurate prediction of HbA1c by continuous glucose monitoring using a kinetic model with patient-specific parameters for red blood cell lifespan and glucose uptake	7
Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes – mediation by pigment epithelium-derived factor	7
Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy	7
Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study	7

Sleep behaviours and associated habits and the progression of pre-diabetes to type 2 diabetes mellitus in adults: A systematic review and meta-analysis	7
Extracellular vesicles in gestational diabetes mellitus: A scoping review	7
Impact of COVID-19 therapy on hyperglycemia	7
Association of triglyceride-glucose with cardiac hemodynamics in type 2 diabetes	6
Hyperinsulinemia alters insulin receptor presentation and internalization in brain microvascular endothelial cells	6
Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis	6
Genetic variation in CARD8, a gene coding for an NLRP3 inflammasome-associated protein, alters the genetic risk for diabetic nephropathy in the context of type 2 diabetes mellitus	6
Relation of Helicobacter pylori infection to peripheral arterial stiffness and 10-year cardiovascular risk in subjects with diabetes mellitus	6
Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis	6
Mean and variability of annual haemoglobin A1c are associated with high-risk peripheral artery disease	6
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis	6
SENP3 regulates high glucose-induced endothelial dysfunction via ROS dependent signaling	6
Risk of orthostatic hypotension associated with sodium-glucose cotransporter-2 inhibitor treatment: A meta-analysis of randomized controlled trials	6
Systolic dysfunction in asymptomatic type 2 diabetic patients, a harbinger of microvascular complications: A cross-sectional study from North India	5
Glucolipotoxicity induces endothelial cell dysfunction by activating autophagy and inhibiting autophagic flow	5
Inhibition of myeloperoxidase increases revascularization and improves blood flow in a diabetic mouse model of hindlimb ischaemia	5
DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice	5
High cardiovascular risk of patients with type 2 diabetes is only partially attributed to angiographic burden of atherosclerosis	5
Insulin increases central aortic stiffness in response to hyperglycemia in healthy humans: A randomized four-arm study	5
Deteriorated regional calf microcirculation measured by contrast-free MRI in patients with diabetes mellitus and relation with physical activity	5
Anti-inflammatory and atheroprotective properties of glucagon	5
Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study	5
Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)	5
Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2	5
Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes	5
Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: A study from the Western Denmark Heart Registry	5
Endothelial deletion of PKCδ prevents VEGF inhibition and restores blood flow reperfusion in diabetic ischemic limb	5
Silencing of FOS-like antigen 1 represses restenosis via the ERK/AP-1 pathway in type 2 diabetic mice	5
Glucose-dependent insulinotropic polypeptide inhibits cardiac hypertrophy and fibrosis in diabetic mice via suppression of TGF-β2	4
Do toe blood pressures predict healing after minor lower limb amputation in people with diabetes? A systematic review and meta-analysis	4
Alteration of autophagy-related protein 5 (ATG5) levels and Atg5 gene expression in diabetes mellitus with and without complications	4
Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment	4
Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment	4
Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome	4
Diabetes mellitus is associated with an increased incidence of aortic valve stenosis	4
Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial	4
Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis	4
Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis	4
Age-associated decline of monocyte insulin sensitivity in diabetic and healthy individuals	4
Restoration of coronary microvascular function by OGA overexpression in a high-fat diet with low-dose streptozotocin-induced type 2 diabetic mice	4
Coronary flow impairment in asymptomatic patients with early stage type-2 diabetes: Detection by FFR_CT	4
Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with ty	4
Impact of diabetes on outcomes of cardiogenic shock: A systematic review and meta-analysis	4
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study	4
Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey	3
Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA	3
Triglyceride glucose index is independently associated with aortic intima-media thickness in patients without known atherosclerotic cardiovascular disease or diabetes	3
Circulating microRNAs are associated with variability in fasting blood glucose over 12-months and target pathways related to type 2 diabetes: A pilot study	3
Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control	3
Coronary artery calcium score and coronary computed tomography angiography predict one-year mortality in patients with type 2 diabetes and peripheral artery disease undergoing partial foot amputation	3